Jundishapur Journal of Microbiology

Published by: Kowsar

The Effect of IL28B Gene Polymorphism on Treatment Response in Iranian Patients with Hepatitis C Virus Infection

Fateme Zare 1 , Hossein Hadinedoushan 1 , * , Mohsen Akhondi Meybodi 2 , Mahdi Dehghanmanshadi 1 , Seyyed Ali Mirghanizade Bafghi 1 and Mahmood Vakili 3
Authors Information
1 Department of Immunology, Reproductive Immunology Research Center, Shahid Sadoughi University of Medical Sciences, Yazd, IR Iran
2 Depatment of Gastrology, Faculty of Medicine, Shahid Sadoughi Hospital, Shahid Sadoughi University of Medical Sciences, Yazd, IR Iran
3 Department of Community, Faculty of Medicine, Shahid Sadoughi University of Medical Sciences, Yazd, IR Iran
Article information
  • Jundishapur Journal of Microbiology: December 01, 2016, 9 (12); e31501
  • Published Online: September 14, 2016
  • Article Type: Research Article
  • Received: July 16, 2015
  • Revised: April 27, 2016
  • Accepted: August 14, 2016
  • DOI: 10.5812/jjm.31501

To Cite: Zare F, Hadinedoushan H, Akhondi Meybodi M, Dehghanmanshadi M, Mirghanizade Bafghi S A, et al. The Effect of IL28B Gene Polymorphism on Treatment Response in Iranian Patients with Hepatitis C Virus Infection, Jundishapur J Microbiol. 2016 ; 9(12):e31501. doi: 10.5812/jjm.31501.

Copyright © 2016, Ahvaz Jundishapur University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
  • 1. Dustin LB, Rice CM. Flying under the radar: the immunobiology of hepatitis C. Annu Rev Immunol. 2007; 25: 71-99[DOI][PubMed]
  • 2. Shepard CW, Finelli L, Alter MJ. Global epidemiology of hepatitis C virus infection. Lancet Infect Dis. 2005; 5(9): 558-67[DOI]
  • 3. Sarrazin C, Susser S, Doehring A, Lange CM, Muller T, Schlecker C, et al. Importance of IL28B gene polymorphisms in hepatitis C virus genotype 2 and 3 infected patients. J Hepatol. 2011; 54(3): 415-21[DOI][PubMed]
  • 4. Tungol A, Rademacher K, Schafer JA. Formulary management of the protease inhibitors boceprevir and telaprevir for chronic hepatitis C virus. J Manag Care Pharm. 2011; 17(9): 685-94[DOI][PubMed]
  • 5. Riva E, Scagnolari C, Monteleone K, Selvaggi C, Picardi A, Mazzarelli C, et al. Interleukin-28B (IL-28B) single-nucleotide polymorphisms and interferon plus ribavirin treatment outcome in Italian chronically HCV-infected patients. J Viral Hepat. 2012; 19(9): 650-3[DOI][PubMed]
  • 6. Powell EE, Edwards-Smith CJ, Hay JL, Clouston AD, Crawford DH, Shorthouse C, et al. Host genetic factors influence disease progression in chronic hepatitis C. Hepatology. 2000; 31(4): 828-33[DOI][PubMed]
  • 7. Thio CL. Host genetic factors and antiviral immune responses to hepatitis C virus. Clin Liver Dis. 2008; 12(3): 713-26[DOI][PubMed]
  • 8. Witte K, Witte E, Sabat R, Wolk K. IL-28A, IL-28B, and IL-29: promising cytokines with type I interferon-like properties. Cytokine Growth Factor Rev. 2010; 21(4): 237-51[DOI][PubMed]
  • 9. Yu ML, Huang CF, Huang JF, Chang NC, Yang JF, Lin ZY, et al. Role of interleukin-28B polymorphisms in the treatment of hepatitis C virus genotype 2 infection in Asian patients. Hepatology. 2011; 53(1): 7-13[DOI][PubMed]
  • 10. Huang CF, Yeh ML, Huang JF, Yang JF, Hsieh MY, Lin ZY, et al. Host interleukin-28B genetic variants versus viral kinetics in determining responses to standard-of-care for Asians with hepatitis C genotype 1. Antiviral Res. 2012; 93(2): 239-44[DOI][PubMed]
  • 11. Shi X, Pan Y, Wang M, Wang D, Li W, Jiang T, et al. IL28B genetic variation is associated with spontaneous clearance of hepatitis C virus, treatment response, serum IL-28B levels in Chinese population. PLoS One. 2012; 7(5): 37054[DOI][PubMed]
  • 12. Ge D, Fellay J, Thompson AJ, Simon JS, Shianna KV, Urban TJ, et al. Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance. Nature. 2009; 461(7262): 399-401[DOI][PubMed]
  • 13. Suppiah V, Moldovan M, Ahlenstiel G, Berg T, Weltman M, Abate ML, et al. IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy. Nat Genet. 2009; 41(10): 1100-4[DOI][PubMed]
  • 14. Tanaka Y, Nishida N, Sugiyama M, Kurosaki M, Matsuura K, Sakamoto N, et al. Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C. Nat Genet. 2009; 41(10): 1105-9[DOI][PubMed]
  • 15. Chu TW, Kulkarni R, Gane EJ, Roberts SK, Stedman C, Angus PW, et al. Effect of IL28B genotype on early viral kinetics during interferon-free treatment of patients with chronic hepatitis C. Gastroenterology. 2012; 142(4): 790-5[DOI][PubMed]
  • 16. Asselah T, De Muynck S, Broet P, Masliah-Planchon J, Blanluet M, Bieche I, et al. IL28B polymorphism is associated with treatment response in patients with genotype 4 chronic hepatitis C. J Hepatol. 2012; 56(3): 527-32[DOI][PubMed]
  • 17. Xie JQ, Guo XY, Zhang XH, Lin BL, Xie DY, Gao ZL, et al. Relationship between the genetic variation in interleukin 28B and response to antiviral therapy in patients with chronic hepatitis C. Chin Med J (Engl). 2012; 125(13): 2334-8[PubMed]
  • 18. Falleti E, Bitetto D, Fabris C, Cussigh A, Fornasiere E, Cmet S, et al. Role of interleukin 28B rs12979860 C/T polymorphism on the histological outcome of chronic hepatitis C: relationship with gender and viral genotype. J Clin Immunol. 2011; 31(5): 891-9[DOI][PubMed]
  • 19. Akuta N, Suzuki F, Hirakawa M, Kawamura Y, Yatsuji H, Sezaki H, et al. Amino acid substitution in hepatitis C virus core region and genetic variation near the interleukin 28B gene predict viral response to telaprevir with peginterferon and ribavirin. Hepatology. 2010; 52(2): 421-9[DOI][PubMed]
  • 20. Sharafi H, Pouryasin A, Alavian SM, Behnava B, Keshvari M, Salimi S. Distribution of IL28B genotypes in Iranian patients with chronic hepatitis C and healthy individuals. Hepat Mon. 2012; 12(12)[DOI]
  • 21. Daneshvar M, Agahsadeghi MR, Mahmazi S, Sadat SM. The Effects of Single Nucleotide Polymorphism of IL28B Gene (rs12979860) on Treatment Response to Pegylated Interferon/Ribavirin in Iranian Patients with Hepatitis C. J Mazandaran Univ Med Sci. 2014; 24(116): 41-51
  • 22. McCarthy JJ, Li JH, Thompson A, Suchindran S, Lao XQ, Patel K, et al. Replicated association between an IL28B gene variant and a sustained response to pegylated interferon and ribavirin. Gastroenterology. 2010; 138(7): 2307-14[DOI][PubMed]
  • 23. Hadinedoushan H, Salmanroghani H, Amirbaigy MK, Akhondi-Meybodi M. Hepatitis C virus genotypes and association with viral load in yazd, central province of iran. Hepat Mon. 2014; 14(3): 11705[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments